Jubilant Pharmova Limited

BSE:530019 Stock Report

Market Cap: ₹168.3b

Jubilant Pharmova Management

Management criteria checks 1/4

Jubilant Pharmova's CEO is Priyavrat Bhartia, appointed in Jun 2023, has a tenure of 1.5 years. total yearly compensation is ₹67.47M, comprised of 37.1% salary and 62.9% bonuses, including company stock and options. directly owns 0.88% of the company’s shares, worth ₹1.49B. The average tenure of the management team and the board of directors is 1.9 years and 6.9 years respectively.

Key information

Priyavrat Bhartia

Chief executive officer

₹67.5m

Total compensation

CEO salary percentage37.1%
CEO tenure1.5yrs
CEO ownership0.9%
Management average tenure1.9yrs
Board average tenure6.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Priyavrat Bhartia's remuneration changed compared to Jubilant Pharmova's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹6b

Jun 30 2024n/an/a

₹6b

Mar 31 2024₹67m₹25m

₹771m

Compensation vs Market: Priyavrat's total compensation ($USD794.09K) is above average for companies of similar size in the Indian market ($USD470.45K).

Compensation vs Earnings: Insufficient data to compare Priyavrat's compensation with company performance.

CEO

Priyavrat Bhartia (48 yo)

1.5yrs

Tenure

₹67,466,997

Compensation

Mr. Priyavrat Bhartia, MBA, is the Non-Executive Chairman at Digicontent Limited and has been its Non-Executive Director since August 14, 2017. He has been Non-Executive Director of Hindustan Media Venture...

Leadership Team

NamePositionTenureCompensationOwnership
Priyavrat Bhartia
MD & Director1.5yrs₹67.47m0.88%
₹ 1.5b
Arjun Bhartia
Joint MD & Director1.5yrs₹67.47mno data
Arvind Chokhany
Group CFO & Whole-Time Director1.6yrs₹44.78mno data
Prakash Bisht
Executive VP of Group Accountsno datano datano data
Laxshmivarahan Ramasubramani
Group Chief Digital & Information Officerno data₹16.53mno data
Surajit Pal
Head of Investor Relationsno datano datano data
Sanjay Gupta
Executive VP & Head of Legal10.1yrs₹3.34mno data
Naresh Kapoor
Company Secretary & Compliance Officer2.3yrs₹6.86mno data
Shantanu Jha
Group Chief Human Resources Officer1.9yrsno datano data
Rajagopal Sankaraiah
Advisor4.8yrs₹67.29mno data
A. Srivastava
Senior Vice President of Corporate Affairsno datano datano data
Chandan Sengar
President of Life Science Chemicalsno data₹19.34mno data

1.9yrs

Average Tenure

55yo

Average Age

Experienced Management: 530019's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Priyavrat Bhartia
MD & Director7.6yrs₹67.47m0.88%
₹ 1.5b
Arjun Bhartia
Joint MD & Director7.6yrs₹67.47mno data
Arvind Chokhany
Group CFO & Whole-Time Director3.7yrs₹44.78mno data
Arul Ramakrishan
Additional Director & Whole-time Directorless than a yearno datano data
Shyam Sunder Bhartia
Chairman46.5yrsno data0.085%
₹ 142.7m
Sushil Roongta
Independent Non-Executive Director7.6yrs₹2.59mno data
Arun Seth
Independent Non-Executive Director6.2yrs₹2.01m0.0013%
₹ 2.1m
Harsh Mahajan
Independent Directorless than a yearno datano data
Hari Bhartia
Co-Chairman41.1yrs₹124.06m0.23%
₹ 394.6m
Shivpriya Nanda
Independent Directorless than a yearno datano data
Vivek Mehra
Independent Non-Executive Director7.6yrs₹2.53mno data
Shirish Belapure
Additional Independent Non-Executive Director1.8yrs₹2.23mno data

6.9yrs

Average Tenure

66yo

Average Age

Experienced Board: 530019's board of directors are considered experienced (6.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 08:17
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jubilant Pharmova Limited is covered by 31 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Harith AhamedAvendus Spark
Deepak KhetanAxis Capital Limited
Gaurav ChughBatlivala & Karani Securities India Pvt. Ltd.